CS2164 exerts an antitumor effect against human Non‐Hodgkin's lymphomas in vitro and in vivo
Sign Up to like & getrecommendations! Published in 2018 at "Experimental Cell Research"
DOI: 10.1016/j.yexcr.2018.05.038
Abstract: Abstract Non‐Hodgkin's lymphomas (NHLs) are a heterogeneous group of lymphoproliferative disorders. Mounting studies have suggested an involvement of angiogenesis signaling in NHLs progression and resistance to treatment. In this study, we investigated the cytotoxicity of… read more here.
Keywords: hodgkin lymphomas; cs2164 exerts; vivo; non hodgkin ... See more keywords
Discrimination of subtypes and stages of non-Hodgkin lymphomas using serum laser-induced breakdown spectroscopy
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Analytical Atomic Spectrometry"
DOI: 10.1039/d5ja00212e
Abstract: Non-Hodgkin lymphomas (NHLs) are a major group of lymphomas. Accurate diagnosis of subtypes and stages of NHLs plays an important role in clinical practices for precise treatment and prognosis evaluation... read more here.
Keywords: non hodgkin; spectroscopy; hodgkin lymphomas; subtypes stages ... See more keywords
Update on the classification of T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms
Sign Up to like & getrecommendations! Published in 2019 at "Expert Review of Hematology"
DOI: 10.1080/17474086.2019.1647777
Abstract: ABSTRACT Introduction: The classification of lymphomas is based on the postulated normal counterparts of lymphoid neoplasms and currently constitutes over 100 definite or provisional entities. As this number of entities implies, lymphomas show marked pathological,… read more here.
Keywords: cell neoplasms; hodgkin lymphomas; classification; lymphomas histiocytic ... See more keywords
Oral and maxillofacial non-Hodgkin lymphomas
Sign Up to like & getrecommendations! Published in 2017 at "Medicine"
DOI: 10.1097/md.0000000000007890
Abstract: Rationale: Lymphomas take up about 14% of all head-neck malignancies, out of which 97% are non-Hodgkin lymphomas (NHL). The clinical courses, treatment responses, and prognoses of NHLs vary with different subtypes and anatomic sites. In… read more here.
Keywords: hodgkin lymphomas; diagnosis; oral maxillofacial; non hodgkin ... See more keywords
Abstract 139: cfDNA methylation profiling distinguishes lineage-specific hematologic malignancies
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Research"
DOI: 10.1158/1538-7445.am2020-139
Abstract: Introduction: Hematologic (heme) malignancies and their precursor conditions are highly prevalent. They are also diverse in biology, clinical presentation, and outcomes, underlining the importance of differentiating them. Previously, we demonstrated that a blood-based targeted methylation… read more here.
Keywords: hodgkin lymphomas; methylation; heme; cancer ... See more keywords
T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.20.02224
Abstract: PURPOSE Patients with relapsed lymphomas often fail salvage therapies including high-dose chemotherapy and mono-antigen–specific T-cell therapies, highlighting the need for nontoxic, novel treatments. To that end, we clinically tested an autologous T-cell product that targets… read more here.
Keywords: 107 cells; therapy lymphoma; lymphoma using; hodgkin lymphomas ... See more keywords
A phase I study of the EZH2 inhibitor TR115 in patients with relapsed/refractory non-Hodgkin's lymphomas and advanced solid tumors.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.7053
Abstract: 7053 Background: EZH2 gain-of-function mutations and overexpression lead to aberrant H3K27me3 levels and result in tumorigenesis and metastasis, including several categories of B cell and T cell lymphoid malignancies, and it is associated with poor… read more here.
Keywords: non hodgkin; refractory non; lymphoma; relapsed refractory ... See more keywords
Axicabtagene ciloleucel for the treatment of relapsed/refractory B-cell non-Hodgkin's lymphomas.
Sign Up to like & getrecommendations! Published in 2018 at "Drugs of today"
DOI: 10.1358/dot.2018.54.3.2776625
Abstract: B-cell non-Hodgkin's lymphomas are the most common hematological malignancies, which despite improvements in chemo-immunotherapy, carry a uniformly poor prognosis in the relapsed/refractory setting. CD19 is an antigen expressed on the surface of most malignancies arising… read more here.
Keywords: relapsed refractory; cell non; hodgkin lymphomas; treatment ... See more keywords
T-Cell Non-Hodgkin Lymphomas: Spectrum of Disease and the Role of Imaging in the Management of Common Subtypes
Sign Up to like & getrecommendations! Published in 2017 at "Korean Journal of Radiology"
DOI: 10.3348/kjr.2017.18.1.71
Abstract: T-cell non-Hodgkin lymphomas (NHLs) are biologically diverse, uncommon malignancies characterized by a spectrum of imaging findings according to subtype. The purpose of this review is to describe the common subtypes of T-cell NHL, highlight important… read more here.
Keywords: cell non; hodgkin lymphomas; common subtypes; non hodgkin ... See more keywords
A Clinically Applicable Approach to the Classification of B-Cell Non-Hodgkin Lymphomas with Flow Cytometry and Machine Learning
Sign Up to like & getrecommendations! Published in 2020 at "Cancers"
DOI: 10.3390/cancers12061684
Abstract: The immunophenotype is a key element to classify B-cell Non-Hodgkin Lymphomas (B-NHL); while it is routinely obtained through immunohistochemistry, the use of flow cytometry (FC) could bear several advantages. However, few FC laboratories can rely… read more here.
Keywords: cell non; hodgkin lymphomas; machine learning; non hodgkin ... See more keywords
Sting Is Commonly and Differentially Expressed in T- and Nk-Cell but Not B-Cell Non-Hodgkin Lymphomas
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14051186
Abstract: Simple Summary T/NK-cell non-Hodgkin lymphomas (NHLs) represent approximately 10% of all NHLs and most patients have a poor outcome using current treatment options. Molecules involved in the host response against lymphoma cells are currently being… read more here.
Keywords: cell; non hodgkin; lymphomas; expression ... See more keywords